Quinoa protein peptide with hypoglycemic effect and preparation method thereof
Patent Information
- Application Number
- CN202411441435.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-16
- Publication Date
- 2024-11-29
AI Technical Summary
Existing hypoglycemia-lowering drugs have side effects, low bioavailability and ineffective treatment. Find a safe, low-cost food-borne natural product with good hypoglycemia-lowering effects.
Alkaline protease, trypsin and neutral protease are used to hydrolyze quinoa protein peptides that have the effect of lowering blood sugar. By adjusting pH value and enzymatic temperature, the digestion absorption rate and bioavailability of quinoa protein are improved. .
It significantly improves the blood sugar-lowering activity of quinoa protein. The inhibition rate of α-amylase and α-glucosidase by quinoa protein peptide is higher, the molecular weight is smaller, and it is easier to be absorbed by the human body. The blood sugar-lowering effect is better than that of quinoa without hydrolyzed Macroprotein.
Smart Images

Figure CN119040423A_ABST
Abstract
Citation Information
Patent Citations
Quinoa peptide and preparation method and application thereof
CN109234344A
Hypoglycemic quinoa peptide, and preparation method and applications thereof
CN111893157A
Active peptide with functions of reducing blood fat and reducing uric acid as well as preparation method and application of active peptide
CN116064710A
